38 related articles for article (PubMed ID: 20513082)
1. Development of a sensitive and specific nanoparticle-assisted PCR assay for detecting HPV-16 and HPV-18 DNA.
Ma X; Li Y; Liu R; Wei W; Ding C
J Med Virol; 2020 Dec; 92(12):3793-3798. PubMed ID: 32356914
[TBL] [Abstract][Full Text] [Related]
2. Redetection of human papillomavirus type 16 infections of the cervix in mid-adult life.
Ermel A; Shew ML; Imburgia TM; Brown M; Qadadri B; Tong Y; Brown DR
Papillomavirus Res; 2018 Jun; 5():75-79. PubMed ID: 29355777
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus detection using the Abbott RealTime high-risk HPV tests compared with conventional nested PCR coupled to high-throughput sequencing of amplification products in cervical smear specimens from a Gabonese female population.
Moussavou-Boundzanga P; Koumakpayi IH; Labouba I; Leroy EM; Belembaogo E; Berthet N
Virol J; 2017 Dec; 14(1):241. PubMed ID: 29268766
[TBL] [Abstract][Full Text] [Related]
4. Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens.
Iftner T; Wang L; Iftner A; Holz B; Haedicke-Jarboui J; Iftner N; von Wasielewski R; Martus P; Boehmer G
BMC Infect Dis; 2016 Nov; 16(1):672. PubMed ID: 27835974
[TBL] [Abstract][Full Text] [Related]
5. A comparison of different human papillomavirus tests in PreservCyt versus SurePath in a referral population-PREDICTORS 4.
Cuzick J; Ahmad AS; Austin J; Cadman L; Ho L; Terry G; Kleeman M; Ashdown-Barr L; Lyons D; Stoler M; Szarewski A
J Clin Virol; 2016 Sep; 82():145-151. PubMed ID: 27498250
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV assay for human papillomavirus genotyping.
Estrade C; Sahli R
J Clin Microbiol; 2014 Feb; 52(2):607-12. PubMed ID: 24478495
[TBL] [Abstract][Full Text] [Related]
7. Comparing the Performance of Hybrid Capture II and Polymerase Chain Reaction (PCR) for the Identification of Cervical Dysplasia in the Screening and Diagnostic Settings.
Luu HN; Adler-Storthz K; Dillon LM; Follen M; Scheurer ME
Clin Med Insights Oncol; 2013; 7():247-55. PubMed ID: 24137052
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the accuracy of Hybrid Capture II and polymerase chain reaction in detecting clinically important cervical dysplasia: a systematic review and meta-analysis.
Luu HN; Dahlstrom KR; Mullen PD; VonVille HM; Scheurer ME
Cancer Med; 2013 Jun; 2(3):367-90. PubMed ID: 23930214
[TBL] [Abstract][Full Text] [Related]
9. Combination of fluorescence color and melting temperature as a two-dimensional label for homogeneous multiplex PCR detection.
Liao Y; Wang X; Sha C; Xia Z; Huang Q; Li Q
Nucleic Acids Res; 2013 Apr; 41(7):e76. PubMed ID: 23335787
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous detection, genotyping, and quantification of human papillomaviruses by multicolor real-time PCR and melting curve analysis.
Liao Y; Zhou Y; Guo Q; Xie X; Luo E; Li J; Li Q
J Clin Microbiol; 2013 Feb; 51(2):429-35. PubMed ID: 23175255
[TBL] [Abstract][Full Text] [Related]
11. Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study.
Szarewski A; Mesher D; Cadman L; Austin J; Ashdown-Barr L; Ho L; Terry G; Liddle S; Young M; Stoler M; McCarthy J; Wright C; Bergeron C; Soutter WP; Lyons D; Cuzick J
J Clin Microbiol; 2012 Jun; 50(6):1867-73. PubMed ID: 22422852
[TBL] [Abstract][Full Text] [Related]
12. Performance of a New HPV Cervi-Collect Collection and Transportation Kit.
Chernesky M; Huang S; Jang D; Erickson B; Salituro J; Engel H; Gilchrist J; Neuscheler P; Mak WB; Abravaya K
J Oncol; 2012; 2012():503432. PubMed ID: 22174716
[TBL] [Abstract][Full Text] [Related]
13. Visual detection of high-risk human papillomavirus genotypes 16, 18, 45, 52, and 58 by loop-mediated isothermal amplification with hydroxynaphthol blue dye.
Luo L; Nie K; Yang MJ; Wang M; Li J; Zhang C; Liu HT; Ma XJ
J Clin Microbiol; 2011 Oct; 49(10):3545-50. PubMed ID: 21865423
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical and analytical performance of the Abbott Realtime High Risk HPV test to the performance of hybrid capture 2 in population-based cervical cancer screening.
Poljak M; Ostrbenk A; Seme K; Ucakar V; Hillemanns P; Bokal EV; Jancar N; Klavs I
J Clin Microbiol; 2011 May; 49(5):1721-9. PubMed ID: 21430098
[TBL] [Abstract][Full Text] [Related]
15. Performance of the Abbott RealTime high-risk HPV test in women with abnormal cervical cytology smears.
Cuzick J; Ambroisine L; Cadman L; Austin J; Ho L; Terry G; Liddle S; Dina R; McCarthy J; Buckley H; Bergeron C; Soutter WP; Lyons D; Szarewski A
J Med Virol; 2010 Jul; 82(7):1186-91. PubMed ID: 20513082
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the analytical and clinical performances of Abbott RealTime High Risk HPV, Hybrid Capture 2, and DNA Chip assays in gynecology patients.
Park S; Kang Y; Kim DG; Kim EC; Park SS; Seong MW
Diagn Microbiol Infect Dis; 2013 Aug; 76(4):432-6. PubMed ID: 23791386
[TBL] [Abstract][Full Text] [Related]
17. High-risk HPV DNA testing and HPV-16/18 genotyping: what is the clinical application?
Twiggs LB; Hopkins M
J Low Genit Tract Dis; 2011 Jul; 15(3):224-30. PubMed ID: 21716051
[TBL] [Abstract][Full Text] [Related]
18. Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy.
Carcopino X; Henry M; Benmoura D; Fallabregues AS; Richet H; Boubli L; Tamalet C
J Med Virol; 2006 Aug; 78(8):1131-40. PubMed ID: 16789021
[TBL] [Abstract][Full Text] [Related]
19. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
